{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "USD", "regularMarketChangePercent": -7.9620996, "regularMarketPrice": 0.0951, "exchange": "PNK", "shortName": "RESVERLOGIX CORP", "longName": "Resverlogix Corp.", "messageBoardId": "finmb_3103092", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "bookValue": -0.223, "fiftyDayAverage": 0.1172, "fiftyDayAverageChange": -0.022100002, "fiftyDayAverageChangePercent": -0.18856657, "twoHundredDayAverage": 0.1378, "twoHundredDayAverageChange": -0.042699993, "twoHundredDayAverageChangePercent": -0.30986935, "marketCap": 25680138, "priceToBook": -0.4264574, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "earningsTimestamp": 1668114000, "earningsTimestampStart": 1668114000, "earningsTimestampEnd": 1668114000, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.01, "sharesOutstanding": 267799008, "firstTradeDateMilliseconds": 1234535400000, "priceHint": 4, "regularMarketChange": -0.008226998, "regularMarketTime": 1684177532, "regularMarketDayHigh": 0.1001, "regularMarketDayRange": "0.0951 - 0.1001", "regularMarketDayLow": 0.0951, "regularMarketVolume": 100000, "regularMarketPreviousClose": 0.103327, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "Other OTC", "financialCurrency": "USD", "regularMarketOpen": 0.1001, "averageDailyVolume3Month": 81106, "averageDailyVolume10Day": 29780, "fiftyTwoWeekLowChange": 0.005099997, "fiftyTwoWeekLowChangePercent": 0.05666663, "fiftyTwoWeekRange": "0.09 - 0.27", "fiftyTwoWeekHighChange": -0.17490001, "fiftyTwoWeekHighChangePercent": -0.6477778, "fiftyTwoWeekLow": 0.09, "fiftyTwoWeekHigh": 0.27, "marketState": "PRE", "displayName": "Resverlogix", "symbol": "RVXCF"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4820 Richard Road SW", "address2": "Suite 300", "city": "Calgary", "state": "AB", "zip": "T3E 6L1", "country": "Canada", "phone": "403-254-9252", "fax": "403-256-8495", "website": "https://www.resverlogix.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company was founded in 2001 and is headquartered in Calgary, Canada.", "fullTimeEmployees": 19, "companyOfficers": [{"maxAge": 1, "name": "Mr. Donald J. McCaffrey", "title": "Co-Founder, Chairman, Pres, CEO & Sec.", "fiscalYear": 2021, "totalPay": {"raw": 372657, "fmt": "372.66k", "longFmt": "372,657"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aaron Bradley Cann C.A., CPA, CA, CPA, CBV", "title": "Chief Financial Officer", "fiscalYear": 2021, "totalPay": {"raw": 207867, "fmt": "207.87k", "longFmt": "207,867"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ewelina  Kulikowski Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2021, "totalPay": {"raw": 184410, "fmt": "184.41k", "longFmt": "184,410"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jan O. Johansson M.D., Ph.D.", "title": "Sr. VP of Medical Affairs", "fiscalYear": 2021, "totalPay": {"raw": 221871, "fmt": "221.87k", "longFmt": "221,871"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael  Sweeney M.D.", "age": 61, "title": "Sr. VP of Clinical Devel.", "yearBorn": 1961, "fiscalYear": 2021, "totalPay": {"raw": 363592, "fmt": "363.59k", "longFmt": "363,592"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sarah  Zapotichny", "title": "Director of Investor Relations & Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}